Plasmodium vivax sub-patent infections after radical treatment are common in Peruvian patients: results of a 1-year prospective cohort study - Test2 - elhamkhani - TriplyDB

Plasmodium vivax sub-patent infections after radical treatment are common in Peruvian patients: results of a 1-year prospective cohort study

Plasmodium vivax sub-patent infections after radical treatment are common in Peruvian patients: results of a 1-year prospective cohort study

http://www.wikidata.org/entity/Q33813078

about

The history of 20th century malaria control in Peru Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine Amazonian malaria: asymptomatic human reservoirs, diagnostic challenges, environmentally driven changes in mosquito vector populations, and the mandate for sustainable control strategies Platform for Plasmodium vivax vaccine discovery and development Malaria in South America: a drug discovery perspective The anaemia of Plasmodium vivax malaria Therapeutic efficacy of alternative primaquine regimens to standard treatment in preventing relapses by Plasmodium vivax: A systematic review and meta-analysis Epidemiology of Plasmodium vivax Malaria in Peru Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses Prevalence of Malaria Infection and Risk Factors Associated with Anaemia among Pregnant Women in Semiurban Community of Hazaribag, Jharkhand, India Genome-Scale Protein Microarray Comparison of Human Antibody Responses in Plasmodium vivax Relapse and Reinfection The burden of Plasmodium vivax relapses in an Amerindian village in French Guiana Efficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax malaria in the Amazon Basin of Peru.Serologic markers in relation to parasite exposure history help to estimate transmission dynamics of Plasmodium vivax.Multiple-clone activation of hypnozoites is the leading cause of relapse in Plasmodium vivax infection Traditional nets interfere with the uptake of long-lasting insecticidal nets in the Peruvian Amazon: the relevance of net preference for achieving high coverage and use.Modelling the potential of focal screening and treatment as elimination strategy for Plasmodium falciparum malaria in the Peruvian Amazon Region.Novel potent metallocenes against liver stage malaria.Population Genetics of Plasmodium vivax in the Peruvian Amazon Genetic diversity and population structure of genes encoding vaccine candidate antigens of Plasmodium vivax.Population Genetics of Plasmodium vivax in Four Rural Communities in Central Vietnam Assessment of an automated capillary system for Plasmodium vivax microsatellite genotyping.High genetic polymorphism of relapsing P. vivax isolates in northwest Colombia.A validated agent-based model to study the spatial and temporal heterogeneities of malaria incidence in the rainforest environment.Prospective Study of Plasmodium vivax Malaria Recurrence after Radical Treatment with a Chloroquine-Primaquine Standard Regimen in Turbo, Colombia Management of relapsing Plasmodium vivax malaria Population structure and spatio-temporal transmission dynamics of Plasmodium vivax after radical cure treatment in a rural village of the Peruvian Amazon.Molecular markers and genetic diversity of Plasmodium vivax.Micro-epidemiology and spatial heterogeneity of P. vivax parasitaemia in riverine communities of the Peruvian Amazon: A multilevel analysis.Analysis of the genetic variability of PvMSP-3α among Plasmodium vivax in Brazilian field isolates.Continuous Supply of Plasmodium vivax Sporozoites from Colonized Anopheles darlingi in the Peruvian Amazon.Asymptomatic Plasmodium vivax parasitaemia in the low-transmission setting: the role for a population-based transmission-blocking vaccine for malaria elimination.Out of the net: An agent-based model to study human movements influence on local-scale malaria transmission.Acceptability of a herd immunity-focused, transmission-blocking malaria vaccine in malaria-endemic communities in the Peruvian Amazon: an exploratory study.

P2860

Q21033831-09A6C4B7-0EEF-450D-B7E3-A3CD8444161E Q24202900-8D863B94-F62F-4896-837D-9FF2ED7E7D7A Q26860062-02C516D0-473F-4A1A-A342-F8F2C88CB372 Q27021891-B6BD4003-0D93-43BB-A4A3-0A9E8AD8DD47 Q27026447-CA5755CC-AE47-453F-AE33-206078CD83AB Q27026970-6D57B1B0-1866-46F2-A0A3-C008F6A8DDBC Q28076056-624C5D26-D5EE-478D-938E-673941E4CEE2 Q28355360-EF72FD47-7A1C-484E-8F65-87A9655F03E5 Q28553162-4456569E-1F7C-43FF-810E-773618A948B7 Q28603504-48B97EFE-265E-4200-9C71-F801F2E21D54 Q28606685-F91720D2-A7C8-46DC-88E8-FD1ECB7F3B7D Q33590003-0E762C1D-D546-4538-AF98-D7617CC28C51 Q33841091-1D17FD5D-6F07-44C4-86CA-5FF816F78F14 Q34091277-386070D1-A6A9-4806-A929-B15B3EC2702D Q34490613-50BD9B76-A0F6-4F35-8E52-A77E138013AD Q34541978-86E57122-36FF-43C5-BD75-DB763D964EB4 Q35599619-8F9CC5DC-2A65-42C9-B035-F08DF65705EF Q35806217-0669BF7E-D95A-47A9-ACDA-34FC796EC999 Q35894048-1F9DE403-AA12-42FF-934E-B504B4DB9EA6 Q35898837-0D1E65B0-63D5-483C-90C7-13101F135322 Q35922694-46E2D449-5273-4CA7-AE00-79E8E1229D71 Q35986727-BBAFCF5D-CF45-4202-B4A9-9186C83E3DE4 Q36361232-2FDE1707-EF15-4759-A327-A2084784F339 Q36397973-C8724116-07BC-4DC0-A467-7F93F790D1FE Q37120100-50D86A9A-0452-47E6-9F4A-CF7C135E11EF Q37290599-14C7551D-F46C-422B-8CC9-27D9470E8C13 Q37484833-416238D0-718A-4751-B924-D595C1A42516 Q37924602-9062BB38-0896-4018-A7FF-10CC81C6DFC9 Q38932860-9C48B39E-1F0A-463B-ADCD-6CC343E1A46B Q44607051-180FEF4C-0666-4875-8183-719044A5BB70 Q49714961-2D712483-3920-416D-B163-70958F974B5A Q52375272-0F4C1068-52B3-4A02-BDB0-FF786101AFB3 Q52671842-9D6E006D-E8C1-49B4-9659-E5B1A0953E72 Q55104120-0A756894-ADFC-4173-8B6E-4E2B85336E68

P2860

Plasmodium vivax sub-patent infections after radical treatment are common in Peruvian patients: results of a 1-year prospective cohort study

http://www.wikidata.org/entity/Q33813078

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Plasmodium vivax sub-patent in ...... -year prospective cohort study

@ast

Plasmodium vivax sub-patent in ...... -year prospective cohort study

@en

type

label

Plasmodium vivax sub-patent in ...... -year prospective cohort study

@ast

Plasmodium vivax sub-patent in ...... -year prospective cohort study

@en

prefLabel

Plasmodium vivax sub-patent in ...... -year prospective cohort study

@ast

Plasmodium vivax sub-patent in ...... -year prospective cohort study

@en

P1433

Q33813078-843D3591-187C-4A4C-9B49-5762972FC1BE

P1476

Q33813078-261864B6-A062-4125-90F5-1B602F4B2E1D

P2093

Q33813078-0A083169-7641-4E0C-A652-6EFA0881AC5C

Q33813078-2BD6F9F5-786E-49E1-9A82-B934E87DB5B4

Q33813078-4B751D91-6856-4527-AFC4-54EB508DAA19

Q33813078-6FCDC915-C6DB-43C2-BCC1-230E56E3B115

Q33813078-7507F6DF-13E4-4573-AE0C-510DC430341E

Q33813078-7CF219D5-B4E8-4A01-BEB2-ED4C6DA73308

P2860

Q33813078-010CD304-75DA-49BF-8CA7-8F0898BA64A8

Q33813078-038A5F2D-CA7D-4226-9785-3AE4C4FE1074

Q33813078-048C7CCF-554E-4CE2-ACC7-392ED234FD67

Q33813078-0BE75340-4723-4923-A607-9E5C3687DBCC

Q33813078-0D05AB99-E3D8-40D2-89CA-81388FEFD544

Q33813078-194C8F2E-A48C-4B28-A277-97EEE6A7CBA3

Q33813078-2124F30D-1EF5-477A-B6F1-2A029E752A04

Q33813078-251A9057-A74F-4CD4-AD84-683CA29B1B32

Q33813078-33EFF2A0-27C3-4C75-8B26-90F1B2DF5A57

Q33813078-3D41662B-50C9-4ECF-BE2D-3D5B41ABA125

P304

Q33813078-13989B5D-9424-4E77-8D7A-E56A13057FD3

P31

Q33813078-4A685350-FD65-43A7-B0E0-E240C5ECF744

P356

Q33813078-692C9F92-7FD1-4051-8411-4EA52A428974

P407

Q33813078-FC496CF4-46B3-4135-AFAA-74692B8A3013

P433

Q33813078-2434C5E1-B05E-4E33-905F-EFD9A338D090

P478

Q33813078-77B91383-1DE9-4BA5-A9ED-C17FE6124D29

P50

Q33813078-3D8E159C-DE44-4F57-B787-513FF7960A39

Q33813078-4B73DF2D-F1C7-4DA1-9135-2CFD7E8B655D

Q33813078-BA98D258-C796-4A2F-A1E7-DD8542A1AC3F

Q33813078-D2613DFB-A93D-4161-875F-C95FC38FEB2B

P577

Q33813078-AAC44B6B-4A91-4E39-B070-D74D1509760A

P5875

Q33813078-8D06825E-A326-41ED-8E14-24BF489C00B4

P698

Q33813078-778F40DD-6055-40CF-8FC6-C8825B889BFE

P921

Q33813078-7DEE2208-EACE-4CB2-A157-0E4A17DAF0AD

P932

Q33813078-01619A78-9477-4702-B14A-6E841A6333F0

P356

JOURNAL.PONE.0016257

P1433

P1476

Plasmodium vivax sub-patent in ...... -year prospective cohort study

@en

P2093

Alejandro Llanos-Cuentas

http://www.w3.org/2001/XMLSchema#string

Annette Erhart

http://www.w3.org/2001/XMLSchema#string

Hugo Rodriguez

http://www.w3.org/2001/XMLSchema#string

Peter Van den Eede

http://www.w3.org/2001/XMLSchema#string

Tanilu Grande

http://www.w3.org/2001/XMLSchema#string

Veronica E Soto-Calle

http://www.w3.org/2001/XMLSchema#string

P2860

Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community

Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia

LIAN 3.0: detecting linkage disequilibrium in multilocus data. Linkage Analysis.

Epidemiological situation of malaria in Madagascar: baseline data for monitoring the impact of malaria control programmes using serological markers.

Resistance to therapies for infection by Plasmodium vivax

High complexity of Plasmodium vivax infections in symptomatic patients from a rural community in central Vietnam detected by microsatellite genotyping.

Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon.

Multilocus genotyping reveals high heterogeneity and strong local population structure of the Plasmodium vivax population in the Peruvian Amazon.

Modelling a predictable disaster: the rise and spread of drug-resistantmalaria.

A new challenge for malaria control in Brazil: asymptomatic Plasmodium infection--a review.

P304

e16257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0016257

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Dionicia Gamboa

Umberto D'Alessandro

Christopher Delgado-Ratto

P577

2011-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49814256

http://www.w3.org/2001/XMLSchema#string

P698

21297986

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium vivax

P932

3030575

http://www.w3.org/2001/XMLSchema#string